Sale!

EGR2 Gene CMT4E Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EGR2 Gene CMT4E Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the EGR2 gene, which are known to cause Charcot-Marie-Tooth disease type 4E (CMT4E), a rare and severe form of hereditary motor and sensory neuropathy. This condition is characterized by progressive muscle weakness and atrophy, sensory loss, and in some cases, severe neurological impairments. Early detection through genetic testing is crucial for the management and treatment of the disease, allowing for personalized care plans and genetic counseling for affected families.

DNA Labs UAE offers this comprehensive genetic test, employing advanced molecular techniques to accurately detect mutations in the EGR2 gene. The test is priced at 4400 AED, reflecting the intricate process of genetic analysis and the specialized expertise required to interpret the results. By choosing to undergo this test at DNA Labs UAE, patients and their families can expect high-quality service, detailed results, and professional guidance, aiding them in understanding their genetic health and making informed decisions about their care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EGR2 Gene CMT4E Genetic Test

Components: EGR2 Gene CMT4E Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for EGR2 Gene CMT4E NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EGR2 Gene CMT4E.

Test Details: The EGR2 gene is associated with a type of Charcot-Marie-Tooth disease called CMT4E. CMT4E is a rare, inherited neurological disorder that affects the peripheral nerves and causes muscle weakness and wasting, as well as sensory loss in the limbs. NGS (next-generation sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. This allows for faster and more comprehensive analysis of genetic mutations associated with CMT4E. NGS genetic testing for CMT4E involves sequencing the entire EGR2 gene to identify any mutations or variations that may be causing the disease. This information can be used to make an accurate diagnosis, provide genetic counseling, and guide treatment options. Overall, NGS genetic testing for CMT4E can help individuals and families affected by this rare disease to better understand its underlying genetic causes and potentially improve their quality of life through early detection and management of symptoms.

Test Name EGR2 Gene CMT4E Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EGR2 Gene CMT4E NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EGR2 Gene CMT4E
Test Details

The EGR2 gene is associated with a type of Charcot-Marie-Tooth disease called CMT4E. CMT4E is a rare, inherited neurological disorder that affects the peripheral nerves and causes muscle weakness and wasting, as well as sensory loss in the limbs.

NGS (next-generation sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. This allows for faster and more comprehensive analysis of genetic mutations associated with CMT4E.

NGS genetic testing for CMT4E involves sequencing the entire EGR2 gene to identify any mutations or variations that may be causing the disease. This information can be used to make an accurate diagnosis, provide genetic counseling, and guide treatment options.

Overall, NGS genetic testing for CMT4E can help individuals and families affected by this rare disease to better understand its underlying genetic causes and potentially improve their quality of life through early detection and management of symptoms.